Condition:   Ridge Preservation Technique
Intervention:   Drug: The effect of tetracycline in degradation and permeability of collagen membranes.
Sponsor:   Universitat Internacional de Catalunya
Completed - verified February 2014

Condition:   Helicobacter Pylori Infection
Interventions:   Drug: Standard Triple;   Drug: Sequential;   Drug: Quadruple
Sponsors:   University of Alberta;   Alberta Innovates Health Solutions;   ArcticNet;   Canadian Institutes of Health Research (CIHR)
Enrolling by invitation - verified October 2013

Condition:   Helicobacter Eradication
Intervention:   Drug: Helicobacter pylori eradication
Sponsors:   Ajou University School of Medicine;   Ajou University School of Medicine
Not yet recruiting - verified September 2013

Condition:   Helicobacter Pylori Infection
Intervention:   Drug: triple, quadruple, non-bismuth quadruple therapy
Sponsors:   National Taiwan University Hospital;   National Taiwan University Hospital
Not yet recruiting - verified June 2013

Conditions:   Colorectal Cancer;   Head and Neck Cancer
Interventions:   Drug: Doxycycline;   Drug: Hydrocortisone 1% cream;   Other: Sunscreen;   Other: Moisturizer;   Drug: Clindamycin;   Drug: Medrol-dose pack (Steroid)
Sponsors:   James Graham Brown Cancer Center;   James Graham Brown Cancer Center;   University of Louisville
Not yet recruiting - verified June 2013

Conditions:   Skin Rash;   Lung Cancer
Intervention:   Drug: Tetracycline
Sponsors:   Instituto Nacional de Cancerologia de Mexico;   Instituto Nacional de Cancerologia de Mexico
Active, not recruiting - verified June 2013

Condition:   Oral Helicobacter Pylori
Interventions:   Drug: Amoxicillin and Tetracyclines;   Drug: Mouth washing
Sponsors:   Ameritek USA;   Ameritek USA
Completed - verified May 2013

Condition:   Helicobacter Infections
Interventions:   Drug: esomeprazole;   Drug: tripotassium dicitrate bismuthate;   Drug: metronidazole;   Drug: tetracycline;   Drug: moxifloxacin;   Drug: amoxicillin
Sponsors:   Seoul National University Bundang Hospital;   Seoul National University Bundang Hospital
Completed - verified February 2013

Conditions:   Chalazia;   Chalazion
Intervention:   Drug: Tetracycline
Sponsors:   The Cleveland Clinic;   The Cleveland Clinic
Not yet recruiting - verified January 2013

Condition:   Helicobacter Pylori Infection
Interventions:   Drug: Sequential therapy;   Drug: Quadruple therapy
Sponsors:   The University of Hong Kong;   The University of Hong Kong
Completed - verified January 2013

Condition:   Osteoporosis
Interventions:   Drug: Teriparatide;   Drug: Denosumab;   Drug: Demeclocyline;   Drug: Tetracycline;   Drug: Calcium Supplement;   Drug: Vitamin D
Sponsors:   Eli Lilly and Company;   Eli Lilly and Company
Not yet recruiting - verified December 2012

Condition:   Cure Rate of Helicobacter Pylori Infection
Interventions:   Drug: Proton pump inhibitor;   Drug: Bismuth subsalicylate;   Drug: Metronidazole;   Drug: Tetracycline;   Drug: Amoxicillin;   Drug: Levofloxacin
Sponsors:   Shanghai Jiao Tong University School of Medicine;   Shanghai Jiao Tong University School of Medicine
Recruiting - verified November 2012

Conditions:   Mumps;   Rubella;   Measles;   Varicella
Interventions:   Biological: Priorix-Tetra™;   Other: Safety data collection
Sponsors:   GlaxoSmithKline;   GlaxoSmithKline
Not yet recruiting - verified November 2012

Conditions:   Functional Dyspepsia;   Scarred Peptic Ulcer
Interventions:   Drug: Proton Pump Inhibitor;   Drug: Bismuth;   Drug: Metronidazole;   Drug: Tetracycline;   Drug: Furazolidone;   Drug: Amoxicillin
Sponsors:   Shanghai Jiao Tong University School of Medicine;   Shanghai Jiao Tong University School of Medicine
Recruiting - verified July 2012

Conditions:   Urethritis;   Cervicitis;   Genital Mycoplasma Infection;   Chlamydia Trachomatis
Interventions:   Drug: Azithromycin;   Drug: Doxycycline;   Drug: lymecycline
Sponsors:   Ostergotland County Council, Sweden;   Ostergotland County Council, Sweden;   Statens Serum Institut, Copenhagen, Denmark
Recruiting - verified August 2012

Condition:   Helicobacter Pylori Infection
Intervention:   Drug: Second-line quadruple therapy with endonase
Sponsors:   Chuncheon Sacred Heart Hospital;   Chuncheon Sacred Heart Hospital
Recruiting - verified July 2012

Condition:   Infections, Bacterial
Intervention:   Drug: Antibiotic prescription during the study period between January 1, 2004 and December 31, 2009
Sponsors:   GlaxoSmithKline;   GlaxoSmithKline
Active, not recruiting - verified April 2012

Condition:   Helicobacter Pylori Infection
Interventions:   Drug: 5RA-5RCM;   Drug: 5RA-5RCT;   Drug: 10RCA
Sponsors:   Buddhist Tzu Chi General Hospital;   Buddhist Tzu Chi General Hospital
Completed - verified April 2012

Condition:   Angelman Syndrome
Intervention:   Drug: minocycline
Sponsor:   University of South Florida
Not yet recruiting - verified February 2012

Condition:   H Pylori Treatment
Interventions:   Drug: Lansoprazole , Tab Amoxycillin , Tab Clarithromycin ,Tab Tinidazole;   Drug: Lansoprazole, Bismuth Subsalicylate, Metronidazole, Tetracycline
Sponsor:   Soroka University Medical Center
Not yet recruiting - verified November 2011